Best Supplements for Reduced C-Reactive Protein Levels
Ranked by research evidence. Compare 105 supplements across 157 papers from the biomedical literature, with effect direction, evidence strength, and dose range for each.
Top picks by evidence
- High evidence7 studies
Across 7 studies, 6 reported beneficial effects on reducing C-reactive protein (CRP) levels, with effect sizes ranging from small to large, most commonly moderate. The most frequently studied doses were 2–3 g/day, and the median study duration was only 7 days, indicating short-term effects. Populations included clinical patients with various inflammatory conditions such as sepsis, migraine, NAFLD, and COVID-19.
Dose: 2-3 g/day - Moderate evidence9 studies
Across 9 studies, 5 reported beneficial moderate-sized effects on reducing C-reactive protein levels, while 4 found no significant effect. The evidence suggests a moderate effect size in clinical populations, with effects typically observed over approximately 16 weeks (median study duration 112 days).
Product matchViva Naturals — Vitamin D3 with Organic Liquid Coconut Oil125 mcg · $15.16 · ★5.0 (208) - Moderate evidence5 studies
Across 5 studies, 4 reported beneficial effects of turmeric (curcumin) on reducing C-reactive protein levels, with effect sizes predominantly moderate. The evidence is drawn largely from meta-analyses in clinical populations (rheumatoid arthritis, type 2 diabetes, metabolic syndrome) and one null trial in athletes. Median study duration was 42 days (from one study), and the only reported dose was 2 g/day.
- HighL-CarnitineAcross 7 studies, 6 reported beneficial effects on reducing C-reactive protein (CRP) levels, with effect sizes ranging from small to large, most commonly moderate. The most frequently studied doses were 2–3 g/day, and the median study duration was only 7 days, indicating short-term effects. Populations included clinical patients with various inflammatory conditions such as sepsis, migraine, NAFLD, and COVID-19. · Dose: 2-3 g/day6 beneficial1 neutral7 studies
- ModerateVitamin DAcross 9 studies, 5 reported beneficial moderate-sized effects on reducing C-reactive protein levels, while 4 found no significant effect. The evidence suggests a moderate effect size in clinical populations, with effects typically observed over approximately 16 weeks (median study duration 112 days).5 beneficial4 neutral9 studies
- ModerateTurmericAcross 5 studies, 4 reported beneficial effects of turmeric (curcumin) on reducing C-reactive protein levels, with effect sizes predominantly moderate. The evidence is drawn largely from meta-analyses in clinical populations (rheumatoid arthritis, type 2 diabetes, metabolic syndrome) and one null trial in athletes. Median study duration was 42 days (from one study), and the only reported dose was 2 g/day.4 beneficial1 neutral5 studies
- ModeratePropolisAcross 3 meta-analyses, all reported beneficial moderate-to-large reductions in C-reactive protein (CRP) levels with propolis supplementation. The strongest evidence comes from a 2025 systematic review of 12 RCTs in people with type 2 diabetes, showing a moderate effect (MD = -2.68, 95% CI: -3.48 to -1.89). Effect sizes were predominantly moderate across studies.3 beneficial3 studies
- ModerateBlack CuminAcross 3 meta-analyses, all 3 reported beneficial moderate-sized effects of black cumin (Nigella sativa) supplementation on reducing C-reactive protein levels. The most-studied dose range, reported in one study, was 200 to 4600 mg/day, and the median study duration was only 7 days (reported in 1 of 3 studies), indicating that longer-term effects remain unclear.3 beneficial3 studies
- LowMagnesiumAcross 3 studies, 2 reported beneficial effects of magnesium on reducing C-reactive protein (CRP) levels, with effect sizes ranging from small to moderate, while 1 study found no effect. The beneficial effects were statistically significant in both supporting studies, which were systematic reviews of clinical populations (metabolic syndrome and overweight/obese individuals). Effects were typically observed at a median study duration of 86 days (~12 weeks), but the evidence base is small and preliminary.2 beneficial1 neutral3 studies
- LowSoy ProteinAcross 3 studies, one meta-analysis reported a moderate beneficial effect of soy protein on reducing C-reactive protein (CRP) in adults with chronic inflammatory diseases, while two other studies (a meta-analysis and an RCT) found no significant effect. The predominant effect size is mixed (small to moderate). The median study duration was 90 days, and the most studied dose was 40 g/day.1 beneficial2 neutral3 studies
- LowQuercetinAcross 3 studies, 2 reported neutral effects (small non-significant changes) and 1 reported a beneficial moderate effect. The overall evidence is mixed, with the only beneficial finding coming from a low-quality review (n=34), while a higher-quality RCT and a larger meta-analysis found no significant changes in CRP. Doses ranged from 500 to 3000 mg daily, but no clear dose range emerged; the median study duration in the single study reporting it was 90 days.1 beneficial2 neutral3 studies
- LowOlive OilAcross 3 studies, 1 reported a small beneficial effect of extra virgin olive oil on reducing C-reactive protein levels, while 2 found neutral results. The median study duration was 56 days (8 weeks). Evidence is limited and preliminary, with the sole beneficial finding coming from a meta-analysis of 1138 participants, whereas smaller meta-analyses and RCTs showed no significant effect.1 beneficial2 neutral3 studies
- LowAlmondAcross 3 meta-analyses, almond intake showed no statistically significant effect on C-reactive protein (CRP) levels, with all studies reporting neutral small-sized effects. Evidence is limited to clinical populations including patients with type 2 diabetes, but doses and study durations were not consistently reported. No beneficial or harmful effects were observed.3 neutral3 studies
- LowN-Acetyl CysteineAcross 3 studies, all reported neutral effects with small effect sizes. No statistically significant reductions in C-reactive protein (CRP) were observed. The most-studied doses were 600 mg daily and 600 mg twice daily, in populations including older adults with vitamin D deficiency and patients with rheumatoid arthritis. Median study duration was 70 days. · Dose: 600 mg daily to 600 mg twice daily3 neutral3 studies